secwatch / observer
8-K filed November 12, 2024, 6:59 PM ET ticker BGMS CIK 0001130166
other material confidence high sentiment negative materiality 0.75

Bio Green Med Solution, Inc. (BGMS): auditor change — Cyclacel dismisses auditor Crowe over warrant equity classification issue; engages Bush & Associates

Bio Green Med Solution, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Bio Green Med Solution, Inc. engaged Bush & Associates CPA LLP as its auditor.

Action
engagement
Auditor
Bush & Associates CPA LLP
Exact text from the filing
On November 5, 2024, the Audit Committee approved the engagement of Bush as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Bio Green Med Solution, Inc. dismissed Crowe LLP as its auditor.

Action
dismissal
Auditor
Crowe LLP
Successor
Bush & Associates CPA LLP
Exact text from the filing
hange in Registrant ’ s Certifying Accountants (a) Dismissal of Independent Registered Public Accounting Firm On November 5, 2024, the Audit Committee of the Board of Directors (the “Audit Committee”) of Cyclacel Pharmaceuticals, Inc. (the “Company”) approved the dismissal of Crowe LLP, (“Crowe”) as the Company’s independent registered public accounting firm, effective
View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

Bio Green Med Solution, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-24-116875
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.